img

Global Cystic Fibrosis (CF) Therapeutics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cystic Fibrosis (CF) Therapeutics Market Research Report 2024

Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
According to Mr Accuracy reports’s new survey, global Cystic Fibrosis (CF) Therapeutics market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cystic Fibrosis (CF) Therapeutics market research.
Key companies engaged in the Cystic Fibrosis (CF) Therapeutics industry include Vertex Pharmaceuticalsorporated, Gilead, AbbVie,, Novartis AG, F. Hoffmann-La Roche Ltd, Alaxia, Merck & Co., AIT (Advanced Inhalation Therapies) and ALLERGAN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Cystic Fibrosis (CF) Therapeutics were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Cystic Fibrosis (CF) Therapeutics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cystic Fibrosis (CF) Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Segment by Type
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators

Segment by Application


Oral drugs
Inhaled drugs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cystic Fibrosis (CF) Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Pancreatic enzyme supplements
1.2.3 Mucolytics
1.2.4 Bronchodilators
1.2.5 CFTR modulators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Oral drugs
1.3.3 Inhaled drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2018-2034)
2.2 Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
3.5 Cystic Fibrosis (CF) Therapeutics Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2024-2034)
5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2018-2034)
6.2 North America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023)
6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2018-2034)
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023)
7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2018-2034)
8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2018-2034)
9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2018-2034)
10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticalsorporated
11.1.1 Vertex Pharmaceuticalsorporated Company Detail
11.1.2 Vertex Pharmaceuticalsorporated Business Overview
11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.1.5 Vertex Pharmaceuticalsorporated Recent Development
11.2 Gilead
11.2.1 Gilead Company Detail
11.2.2 Gilead Business Overview
11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.2.5 Gilead Recent Development
11.3 AbbVie,
11.3.1 AbbVie, Company Detail
11.3.2 AbbVie, Business Overview
11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.3.5 AbbVie, Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Alaxia
11.6.1 Alaxia Company Detail
11.6.2 Alaxia Business Overview
11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.6.5 Alaxia Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Detail
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.7.5 Merck & Co. Recent Development
11.8 AIT (Advanced Inhalation Therapies)
11.8.1 AIT (Advanced Inhalation Therapies) Company Detail
11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.8.5 AIT (Advanced Inhalation Therapies) Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Detail
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.9.5 ALLERGAN Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.10.5 AstraZeneca Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Alcresta
11.12.1 Alcresta Company Detail
11.12.2 Alcresta Business Overview
11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
11.12.5 Alcresta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Pancreatic enzyme supplements
Table 3. Key Players of Mucolytics
Table 4. Key Players of Bronchodilators
Table 5. Key Players of CFTR modulators
Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2018-2023)
Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2024-2034)
Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
Table 23. Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2024-2034)
Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2018-2023)
Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2024-2034)
Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 48. Vertex Pharmaceuticalsorporated Company Detail
Table 49. Vertex Pharmaceuticalsorporated Business Overview
Table 50. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
Table 51. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 52. Vertex Pharmaceuticalsorporated Recent Development
Table 53. Gilead Company Detail
Table 54. Gilead Business Overview
Table 55. Gilead Cystic Fibrosis (CF) Therapeutics Product
Table 56. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Gilead Recent Development
Table 58. AbbVie, Company Detail
Table 59. AbbVie, Business Overview
Table 60. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
Table 61. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 62. AbbVie, Recent Development
Table 63. Novartis AG Company Detail
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
Table 66. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. F. Hoffmann-La Roche Ltd Company Detail
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 71. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd Recent Development
Table 73. Alaxia Company Detail
Table 74. Alaxia Business Overview
Table 75. Alaxia Cystic Fibrosis (CF) Therapeutics Product
Table 76. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Alaxia Recent Development
Table 78. Merck & Co. Company Detail
Table 79. Merck & Co. Business Overview
Table 80. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
Table 81. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Merck & Co. Recent Development
Table 83. AIT (Advanced Inhalation Therapies) Company Detail
Table 84. AIT (Advanced Inhalation Therapies) Business Overview
Table 85. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
Table 86. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 87. AIT (Advanced Inhalation Therapies) Recent Development
Table 88. ALLERGAN Company Detail
Table 89. ALLERGAN Business Overview
Table 90. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
Table 91. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 92. ALLERGAN Recent Development
Table 93. AstraZeneca Company Detail
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
Table 96. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Teva Pharmaceutical Industries Ltd Company Detail
Table 99. Teva Pharmaceutical Industries Ltd Business Overview
Table 100. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
Table 101. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Ltd Recent Development
Table 103. Alcresta Company Detail
Table 104. Alcresta Business Overview
Table 105. Alcresta Cystic Fibrosis (CF) Therapeutics Product
Table 106. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Alcresta Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2024 VS 2034
Figure 3. Pancreatic enzyme supplements Features
Figure 4. Mucolytics Features
Figure 5. Bronchodilators Features
Figure 6. CFTR modulators Features
Figure 7. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2024 VS 2034
Figure 9. Oral drugs Case Studies
Figure 10. Inhaled drugs Case Studies
Figure 11. Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2024 VS 2034
Figure 15. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2024
Figure 16. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2024
Figure 18. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2018-2034)
Figure 20. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2018-2034)
Figure 24. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Region (2018-2034)
Figure 32. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2018-2034)
Figure 40. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2018-2034)
Figure 44. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 47. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 48. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 49. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 51. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 52. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 53. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 54. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 55. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 57. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries